Nano-Enabled COVID-19 Vaccines: Meeting the Challenges of Durable Antibody Plus Cellular Immunity and Immune Escape
- André E. Nel*
André E. NelDivision of NanoMedicine, Department of Medicine, David Geffen School of Medicine, University of California, Los Angeles, Los Angeles, California 90095, United StatesCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, California 90095, United StatesMore by André E. Nel
- and
- Jeff F. Miller
Jeff F. MillerCalifornia NanoSystems Institute, University of California, Los Angeles, Los Angeles, California 90095, United StatesDepartment of Microbiology, Immunology and Molecular Genetics, University of California, Los Angeles, Los Angeles, California 90095, United StatesMore by Jeff F. Miller
Abstract
At the time of preparing this Perspective, large-scale vaccination for COVID-19 is in progress, aiming to bring the pandemic under control through vaccine-induced herd immunity. Not only does this vaccination effort represent an unprecedented scientific and technological breakthrough, moving us from the rapid analysis of viral genomes to design, manufacture, clinical trial testing, and use authorization within the time frame of less than a year, but it also highlights rapid progress in the implementation of nanotechnology to assist vaccine development. These advances enable us to deliver nucleic acid and conformation-stabilized subunit vaccines to regional lymph nodes, with the ability to trigger effective humoral and cellular immunity that prevents viral infection or controls disease severity. In addition to a brief description of the design features of unique cationic lipid and virus-mimicking nanoparticles for accomplishing spike protein delivery and presentation by the cognate immune system, we also discuss the importance of adjuvancy and design features to promote cooperative B- and T-cell interactions in lymph node germinal centers, including the use of epitope-based vaccines. Although current vaccine efforts have demonstrated short-term efficacy and vaccine safety, key issues are now vaccine durability and adaptability against viral variants. We present a forward-looking perspective of how vaccine design can be adapted to improve durability of the immune response and vaccine adaptation to overcome immune escape by viral variants. Finally, we consider the impact of nano-enabled approaches in the development of COVID-19 vaccines for improved vaccine design against other infectious agents, including pathogens that may lead to future pandemics.
Cited By
This article is cited by 32 publications.
- Warren C. W. Chan, Natalie Artzi, Chunying Chen, Xiaodong Chen, Dean Ho, Tony Hu, Kazunori Kataoka, Luis M. Liz-Marzán, Rahmi Oklu, Wolfgang J. Parak. Noble Nanomedicine: Celebrating Groundbreaking mRNA Vaccine Innovations. ACS Nano 2023, 17 (20) , 19476-19477. https://doi.org/10.1021/acsnano.3c09781
- Ceri J. Richards, Thomas C. Q. Burgers, Rifka Vlijm, Wouter H. Roos, Christoffer Åberg. Rapid Internalization of Nanoparticles by Human Cells at the Single Particle Level. ACS Nano 2023, 17 (17) , 16517-16529. https://doi.org/10.1021/acsnano.3c01124
- Maurice Retout, Benedetta Cornelio, Gilles Bruylants, Ivan Jabin. Bifunctional Calix[4]arene-Coated Gold Nanoparticles for Orthogonal Conjugation. Langmuir 2022, 38 (30) , 9301-9309. https://doi.org/10.1021/acs.langmuir.2c01122
- Nuri Burak Kiremitler, Munteha Zeynep Kemerli, Nilgun Kayaci, Sultan Karagoz, Sami Pekdemir, Gokhan Sarp, Senem Sanduvac, Mustafa Serdar Onses, Erkan Yilmaz. Nanostructures for the Prevention, Diagnosis, and Treatment of SARS-CoV-2: A Review. ACS Applied Nano Materials 2022, 5 (5) , 6029-6054. https://doi.org/10.1021/acsanm.2c00181
- Morgan Chandler, Brittany Johnson, Emil Khisamutdinov, Marina A. Dobrovolskaia, Joanna Sztuba-Solinska, Aliasger K. Salem, Koen Breyne, Roger Chammas, Nils G. Walter, Lydia M. Contreras, Peixuan Guo, Kirill A. Afonin. The International Society of RNA Nanotechnology and Nanomedicine (ISRNN): The Present and Future of the Burgeoning Field. ACS Nano 2021, 15 (11) , 16957-16973. https://doi.org/10.1021/acsnano.0c10240
- Wolfgang J. Parak, (Associate Editor)Tanja Weil, (Editorial Advisory Board and Associate Editor of the Journal of the American Chemical Society)Paul S. Weiss (Editor-in-Chief). A Virtual Issue on Nanomedicine. ACS Nano 2021, 15 (10) , 15397-15401. https://doi.org/10.1021/acsnano.1c09106
- Paul S. Weiss (Editor-in-Chief). Touting the Growing Contributions of Nanoscience and Nanotechnology. ACS Nano 2021, 15 (7) , 10737-10738. https://doi.org/10.1021/acsnano.1c05996
- Istuti Saraswat, Sarmistha Saha, Anuja Mishra. A review of metallic nanostructures against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Toxicology and Environmental Health Sciences 2023, 15 (4) , 315-324. https://doi.org/10.1007/s13530-023-00182-9
- Xirong Wang, Shulin Shao, Huan Ye, Sen Li, Bing Gu, Bo Tang. Development of a quantum dot-based lateral flow immunoassay strip for rapid and sensitive detection of SARS-CoV-2 neutralizing antibodies. Scientific Reports 2023, 13 (1) https://doi.org/10.1038/s41598-023-49244-5
- Yanhao Zhang, Ji Wang, Hanlei Xing, Chao Liu, Wenhui Zha, Shuo Dong, Yuhao Jiang, Xinsong Li. Enhanced immunogenicity induced by mRNA vaccines with various lipid nanoparticles as carriers for SARS-CoV-2 infection. Journal of Materials Chemistry B 2023, 11 (31) , 7454-7465. https://doi.org/10.1039/D3TB00303E
- Tianyu Zhao, Penghui Liang, Jiaqi Ren, Jinyue Zhu, Xianning Yang, Hongyu Bian, Jingwen Li, Xiaofeng Cui, Chunhui Fu, Jinyan Xing, Congying Wen, Jingbin Zeng. Gold-silver alloy hollow nanoshells-based lateral flow immunoassay for colorimetric, photothermal, and SERS tri-mode detection of SARS-CoV-2 neutralizing antibody. Analytica Chimica Acta 2023, 1255 , 341102. https://doi.org/10.1016/j.aca.2023.341102
- Priya Shrivastava, Suresh P. Vyas. COVID-19: Molecular Pathogenesis and Prospective Therapeutic Interventions. 2023, 269-294. https://doi.org/10.1007/978-3-031-20537-8_12
- Mohamed E. Elnosary, Hesham A. Aboelmagd, Manal A. Habaka, Salem R. Salem, Mehrez E. El-Naggar. Synthesis of bee venom loaded chitosan nanoparticles for anti-MERS-COV and multi-drug resistance bacteria. International Journal of Biological Macromolecules 2023, 224 , 871-880. https://doi.org/10.1016/j.ijbiomac.2022.10.173
- Gandarvakottai Senthilkumar Arumugam, Kannan Damodharan, Mukesh Doble, Sathiah Thennarasu. Significant perspectives on various viral infections targeted antiviral drugs and vaccines including COVID-19 pandemicity. Molecular Biomedicine 2022, 3 (1) https://doi.org/10.1186/s43556-022-00078-z
- Lifeng Wang, Zhiwei Li. Smart Nanostructured Materials for SARS-CoV-2 and Variants Prevention, Biosensing and Vaccination. Biosensors 2022, 12 (12) , 1129. https://doi.org/10.3390/bios12121129
- Kevork Oliver Messerian, Anton Zverev, Jack F. Kramarczyk, Andrew L. Zydney. Pressure‐dependent fouling behavior during sterile filtration of mRNA‐containing lipid nanoparticles. Biotechnology and Bioengineering 2022, 119 (11) , 3221-3229. https://doi.org/10.1002/bit.28200
- Rahul Bhattacharjee, Ankit Kumar Dubey, Archisha Ganguly, Basudha Bhattacharya, Yogendra Kumar Mishra, Ebrahim Mostafavi, Ajeet Kaushik. State-of-art high-performance Nano-systems for mutated coronavirus infection management: From Lab to Clinic. OpenNano 2022, 8 , 100078. https://doi.org/10.1016/j.onano.2022.100078
- Ziqi Wang, Kai Cui, Ulrich Costabel, Xiaoju Zhang. Nanotechnology‐facilitated vaccine development during the coronavirus disease 2019 (COVID‐19) pandemic. Exploration 2022, 2 (5) https://doi.org/10.1002/EXP.20210082
- Haoyang Tong, Chaoyu Cao, Minli You, Shuang Han, Zhe Liu, Ying Xiao, Wanghong He, Chang Liu, Ping Peng, Zhenrui Xue, Yan Gong, Chunyan Yao, Feng Xu. Artificial intelligence-assisted colorimetric lateral flow immunoassay for sensitive and quantitative detection of COVID-19 neutralizing antibody. Biosensors and Bioelectronics 2022, 213 , 114449. https://doi.org/10.1016/j.bios.2022.114449
- Jongwon Park. Lateral Flow Immunoassay Reader Technologies for Quantitative Point-of-Care Testing. Sensors 2022, 22 (19) , 7398. https://doi.org/10.3390/s22197398
- João Lima Tavares, Iago Dillion Lima Cavalcanti, Nereide Stela Santos Magalhães, Mariane Cajubá de Britto Lira Nogueira. Nanotechnology and COVID-19: quo vadis?. Journal of Nanoparticle Research 2022, 24 (3) https://doi.org/10.1007/s11051-022-05452-0
- Shivani Tiwari, Subhavna Juneja, Anujit Ghosal, Nandika Bandara, Raju Khan, Scott L. Wallen, Seeram Ramakrishna, Ajeet Kaushik. Antibacterial and antiviral high-performance nanosystems to mitigate new SARS-CoV-2 variants of concern. Current Opinion in Biomedical Engineering 2022, 21 , 100363. https://doi.org/10.1016/j.cobme.2021.100363
- Hylemariam Mihiretie Mengist, John Arnaud Kombe Kombe, Tengchuan Jin. Immune Evasion by the Highly Mutated SARS-CoV-2 Omicron Variant. Infection and Drug Resistance 2022, Volume 15 , 4013-4027. https://doi.org/10.2147/IDR.S366437
- Ali Dogan Dursun, Ersin Saricam, Gulcin Turkmen Sariyildiz, Murat Doğan Iscanli, Ömer Faruk Cantekin. The Evaluation of Oxidative Stress in the Young Adults with COVID-19 mRNA Vaccines Induced Acute Pericarditis- Myopericarditis. International Journal of General Medicine 2022, Volume 15 , 161-167. https://doi.org/10.2147/IJGM.S347977
- Madhura Kamat, Vishakha Kurlawala, Geetanjali Ghosh, Radhika Vaishnav. Immune dynamics of SARS-CoV-2 virus evolution. International Journal of Molecular and Immuno Oncology 2022, 7 , 3-15. https://doi.org/10.25259/IJMIO_26_2021
- Mahdi Pouresmaieli, Elena Ekrami, Ali Akbari, Negin Noorbakhsh, Negin Borzooee Moghadam, Matin Mamoudifard. A comprehensive review on efficient approaches for combating coronaviruses. Biomedicine & Pharmacotherapy 2021, 144 , 112353. https://doi.org/10.1016/j.biopha.2021.112353
- Hui-Tsu Lin, Cheng-Cheung Chen, Der-Jiang Chiao, Tein-Yao Chang, Xin-An Chen, Jenn-Jong Young, Szu-Cheng Kuo. Nanoparticular CpG-adjuvanted SARS-CoV-2 S1 protein elicits broadly neutralizing and Th1-biased immunoreactivity in mice. International Journal of Biological Macromolecules 2021, 193 , 1885-1897. https://doi.org/10.1016/j.ijbiomac.2021.11.020
- Maryam Hojjat Jodaylami, Abdelhadi Djaïleb, Pierre Ricard, Étienne Lavallée, Stella Cellier-Goetghebeur, Megan-Faye Parker, Julien Coutu, Matthew Stuible, Christian Gervais, Yves Durocher, Florence Desautels, Marie-Pierre Cayer, Marie Joëlle de Grandmont, Samuel Rochette, Danny Brouard, Sylvie Trottier, Denis Boudreau, Joelle N. Pelletier, Jean-Francois Masson. Cross-reactivity of antibodies from non-hospitalized COVID-19 positive individuals against the native, B.1.351, B.1.617.2, and P.1 SARS-CoV-2 spike proteins. Scientific Reports 2021, 11 (1) https://doi.org/10.1038/s41598-021-00844-z
- Shahad Saif Khandker, Brian Godman, Md. Irfan Jawad, Bushra Ayat Meghla, Taslima Akter Tisha, Mohib Ullah Khondoker, Md. Ahsanul Haq, Jaykaran Charan, Ali Azam Talukder, Nafisa Azmuda, Shahana Sharmin, Mohd. Raeed Jamiruddin, Mainul Haque, Nihad Adnan. A Systematic Review on COVID-19 Vaccine Strategies, Their Effectiveness, and Issues. Vaccines 2021, 9 (12) , 1387. https://doi.org/10.3390/vaccines9121387
- Lei Qiao, Minmin Chen, Suyan Li, Jinxia Hu, Chaoju Gong, Zhuoqi Zhang, Xichuan Cao. A peptide-based subunit candidate vaccine against SARS-CoV-2 delivered by biodegradable mesoporous silica nanoparticles induced high humoral and cellular immunity in mice. Biomaterials Science 2021, 9 (21) , 7287-7296. https://doi.org/10.1039/D1BM01060C
- Catherine H. Schein, Corri B. Levine, Susan L.F. McLellan, Surendra S. Negi, Werner Braun, Stephen C. Dreskin, Elizabeth S. Anaya, Jurgen Schmidt. Synthetic proteins for COVID-19 diagnostics. Peptides 2021, 143 , 170583. https://doi.org/10.1016/j.peptides.2021.170583
- Abdel-Majed Safer, Stefano Leporatti. Chitosan Nanoparticles for Antiviral Drug Delivery: A Novel Route for COVID-19 Treatment. International Journal of Nanomedicine 2021, Volume 16 , 8141-8158. https://doi.org/10.2147/IJN.S332385